Finally, analyses of another cohort of HGSC patients with extremely good or poor responses to first-line PAC/CBDCA (n = 34) published in 2021 by Willis et al. (see also part 4) failed to reveal a significant link between immunohistochemical SLFN11 levels and sensitivity to PAC/CBDCA (p = 0.487). Here, SLFN11 is linked to gonorrhea.